Abiopharma

OMADA HEALTH, INC. (OMDA)

Symbol	OMDA
Name	OMADA HEALTH, INC.
Sector	HEALTH CARE
Region	North America
Industry	Medical/Nursing Services
Address	500 SANSOME STREET,SUITE 200, SAN FRANCISCO, California, 94111, United States
Telephone	888-987-8337
Fax	—
Email	—
Website	—
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0001611115
Description	Omada Health strives to inspire and enable people to make lasting health changes on their own terms. We deliver virtual care between doctors visits, providing an engaging, personalized, and integrated experience for our members that is designed to improve their health while delivering value for the employers, health plans, health systems, pharmacy benefit managers, and other entities that cover the cost of our programs. As of March 31, 2025, we had more than 2,000 customers and over 679,000 total members enrolled in one or more programs, and we had supported over one million members since launch. Additional info from NASDAQ: Omada Health strives to inspire and enable people to make lasting health changes on their own terms. We deliver virtual care between doctors visits, providing an engaging, personalized, and integrated experience for our members that is designed to improve their health while delivering value for the employers, health plans, health systems, pharmacy benefit managers, and other entities that cover the cost of our programs. As of March 31, 2025, we had more than 2,000 customers and over 679,000 total members enrolled in one or more programs, and we had supported over one million members since launch.

2026-08-14 17:33

New Form SCHEDULE 13G/A - Omada Health, Inc. Filed: 2026-08-14 AccNo: 0000919574-26-005548 Size: 23 KB

2026-08-14 15:51

New Form SCHEDULE 13G - Omada Health, Inc. Filed: 2026-08-14 AccNo: 0000052388-26-000292 Size: 12 KB

2026-08-12 20:50

Shao Wei-Li 🔴 sold 8.9K shares of Omada Health, Inc. (OMDA) at $25.02 Transaction Date: Aug 12, 2026 | Filing ID: 000357

2026-08-12 20:46

Gracey Craig 🟡 adjusted position in 1.0K shares (1 derivative) of Omada Health, Inc. (OMDA) at $25.00 Transaction Date: Aug 10, 2026 | Filing ID: 000355

2026-08-12 20:31

📋 WEI-LI SHAO (Officer) plans to sell 9K shares of Omada Health, Inc. (at $24.01 each, total $213K) Filed: Aug 12, 2026 | ID: 008023

2026-08-11 20:33

📋 Steven Cook (Officer) plans to sell 3K shares of Omada Health, Inc. (at $24.99 each, total $68K) Filed: Aug 11, 2026 | ID: 007973

2026-08-11 20:17

Duffy Sean P. 🟡 adjusted position in 21.6K shares (3 derivative) of Omada Health, Inc. (OMDA) at $24.81 Transaction Date: Aug 07, 2026 | Filing ID: 000354

2026-08-10 20:47

📋 SEAN DUFFY (Director) plans to sell 13K shares of Omada Health, Inc. (at $23.67 each, total $306K) Filed: Aug 10, 2026 | ID: 007907

2026-08-10 20:34

📋 Steven Cook (Officer) plans to sell 15K shares of Omada Health, Inc. (at $23.67 each, total $361K) Filed: Aug 10, 2026 | ID: 007891

2026-08-10 20:33

📋 CRAIG GRACEY (Officer) plans to sell 1K shares of Omada Health, Inc. (at $23.67 each, total $25K) Filed: Aug 10, 2026 | ID: 007886

Trial ID	Title	Phase	Indication	Status	Start Date	Completion Date	Source
NCT05394766	Remote Patient Monitoring and Health Coaching vs. Usual Care for the Treatment …	Na	Hypertension	Completed	2022-07-29	2026-04-15	ClinicalTrials.gov
NCT05368454	Evaluation of a Digital Diabetes Self-Management Education and Support Program	Na	Type 2 Diabetes	Completed	2022-05-31	2024-01-24	ClinicalTrials.gov
NCT04892680	Impact of a Digital Self-Management Program on A1C for Individuals With Type 2 …	Na	Type 2 Diabetes	Terminated	2021-03-04	2021-08-02	ClinicalTrials.gov
NCT03312764	Preventing Diabetes With Digital Health and Coaching	Na	PreDiabetes	Completed	2017-11-01	2020-08-31	ClinicalTrials.gov
NCT02664064	Evaluation of Prevent in Underserved Populations	Na	Prediabetes	Completed	2016-01-01	2018-05-01	ClinicalTrials.gov

Total clinical trials: 5

Product Name	Type	Development Stage	Therapeutic Area	Study Status	Trial ID
Omada Hypertension Program	Other	Approved	Hypertension	COMPLETED	NCT05394766
Omada Hypertension Program	Other	Approved	Hypertension	COMPLETED	NCT05394766
Omada Hypertension Program	Other	Approved	Hypertension	COMPLETED	NCT05394766
Omada Hypertension Program	Other	Approved	Hypertension	COMPLETED	NCT05394766
Omada Hypertension Program	Other	Approved	Hypertension	COMPLETED	NCT05394766
Omada Hypertension Program	Other	Approved	Hypertension	COMPLETED	NCT05394766
Omada Hypertension Program	Other	Approved	Hypertension	COMPLETED	NCT05394766
Omada Hypertension Program	Other	Approved	Hypertension	COMPLETED	NCT05394766
Omada Hypertension Program	Other	Approved	Hypertension	COMPLETED	NCT05394766
Omada Hypertension Program	Other	Approved	Hypertension	COMPLETED	NCT05394766
Omada Hypertension Program	Other	Approved	Hypertension	COMPLETED	NCT05394766
Omada Hypertension Program	Other	Approved	Hypertension	COMPLETED	NCT05394766

Total products: 12